To include your compound in the COVID-19 Resource Center, submit it here.

Biogen Idec beats Street

Biogen Idec Inc. (NASDAQ:BIIB) reported 1Q11 diluted non-GAAP EPS of $1.43, beating by

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE